|
Mersana Therapeutics inc (NASDAQ: MRSN) |
|
Mersana Therapeutics inc
MRSN's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Mersana Therapeutics Inc growth rates, revenue grew
by 63.65 % in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 1295
Major Pharmaceutical Preparations industry recorded
growth of revenues by 9.75 %
Mersana Therapeutics Inc net loss decreased from $-42 millions, to $-12 millions in III. Quarter 2024,
• More on MRSN's Growth
|
|
Mersana Therapeutics Inc realized a net loss in trailing twelve months.
Mersana Therapeutics Inc realized cash reduction of $ -0.88 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
614.77 |
PE TTM
|
|
Company's Price to Sales ratio is at 2.18.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.88.
• More on MRSN's Valuation
|
|
|
|
|
Mersana Therapeutics Inc realized net loss in trailing twelve months.
Mersana Therapeutics Inc realized cash outflow of $ -0.88per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
614.77 |
PE TTM
|
|
Company's Price to Sales ratio is at 2.18.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.88.
Mersana Therapeutics Inc Price to Book Ratio is at 72.37 lower than Industry Avg. of 828.62. and higher than S&P 500 Avg. of 0.01
• More on MRSN's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com